Payday loans

Category Archives: Drugs

REVISED: Preemptive Treatment of Severe Morning Sickness Decreases Suffering for Moms-to-Be

In a study to be presented on February 14 between 1:15 p.m., and 3:30 p.m. PST, at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in San Francisco, California, researchers will present data showing the effectiveness of preemptive treatment for hyperemesis gravidarum and severe morning sickness.

Study Finds That Anti-diabetic Medication Can Prevent the Long Term Effects of Maternal Obesity

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds That Anti-diabetic Medication Can Prevent the Long Term Effects of Maternal Obesity

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that show that short therapy with the anti-diabetic medication Pioglitazone can prevent the long term effects of maternal obesity on offspring.

Study Finds Some Medications May Interact with Common Anti- Recurrent Preterm Birth Medication

Full abstract at the bottom of the page. Click Here to view all 2012 abstracts.

Study Finds Some Medications May Interact with Common Anti- Recurrent Preterm Birth Medication

In a study to be presented today at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting ™, in Dallas, Texas, researchers will report findings that indicate that prescription medications may affect the body’s ability to metabolize 17-alpha-hydroxyprogesterone caproate (17-OHPC), the only FDA approved medication for the prevention of recurrent preterm birth.

2011: Society for Maternal-Fetal Medicine commends senators on letter to KV Pharmaceutical Company

Letter Urges Manufacturer to Drop Pricing of Makena

The Society for Maternal-Fetal Medicine weighed in on a recent letter sent by members of the United States Senate Committee on Health, Education, Labor, and Pensions to Greg Divis and Terry Hatfield with KV Pharmaceutical Company. Divis is the company’s CEO and Hatfield is chairman of the board of directors. Senators Harkin, Mikulski, Murray, Sanders, Casey, Franken, Whitehouse, and Blumenthal each signed the letter requesting the company to lower the price of Makena.

Letter: Senate Committee on Health, Education, Labor, and Pensions to KV Pharmaceuticals

Mssrs. Divis and Hatfield,

We join together today to call on KV Pharmaceuticals to lower the price of Makena, your newly-approved drug used to prevent pre-term birth

Prior to Makena’s approval, the same progesterone treatment was widely available through compounding pharmacies for $10 – $20 per dose. We note your price reduction from the original, shocking, $1,500 to per does to the current list price of $690 per dose as a step in the right direction. At approximately $10,000 for a course of treatment, however, the new price still poses an unreasonable burden on patients and the healthcare system.

Powered by WordPress | Designed by: seo service | Thanks to seo company, web designers and internet marketing company